well friend, 8 billion/yr in revenue in each of the next four years plus billions more in the years after that make GILD a steal at $75. Then there's that cancer drug that GILD is about to launch. You are a fool to beieive that Sovaldi is the only reason to own the company..
It appears that an other shot of BS repellent is needed ...
dopey has been wrong about everything that he's ranted about.
"25% is about right."
Of course delusional dopey hasn't been "about right" a single things so far... LOL!
"So, if it is confidential, how would you know that there is an agreement? "
Maybe someone would be kind enough to spray some BS repellent on giguy ...
Dopey you've been "sure" about a whole lot of things over the last four months -- and none of them have happened.
"Another down day" .. yeah, IDIX has been having lot of them this year -- hasn't it dopey.,
BTW it's down to 6.60 AH today.
one other con -- it's FWHT
ahhh, no it's MIVA ...
ooops, it's VTRO
yuk, it's INUV
actually no one knows what it is -- but investors should recognize a loser when they see one..
Sovaldi increases GILD's revenue by about 80% this year vs last.
Name another large cap company where that is happening..
in the meantime GILD will likely sell $30+ BILLION of Sovaldi thru 2018 -- won't it??
It's not an article, dopey. It's a blog post by someone with your level of intelligence -- none.